Safe Food: The Politics of Food Safety (61 page)

10
. GAO.
Food Safety and Quality: FDA Strategy Needed to Address Animal Drug Residues in Milk
(GAO/RCED-92-209), 1992.
Recombinant Bovine Growth Hormone: FDA Approval Should Be Withheld until the Mastitis Issue Is Resolved
(GAO/PEMD-92-26), 1992.

11
. Kimura T, Murakawa Y, Ohno M, et al. Gastrointestinal absorption of recombinant human insulin-like growth factor 1 in rats.
J Pharmacological and Experimental Therapeutics
1997;283:611–618. Chan JM, Stampfer MJ, Giovannucci E, et al. Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study.
Science
1998;279:563–566. Hankinson SE, Willett WC, Golditz GA, et al. Circulating concentrations of insulin-like growth factor 1 and risk of breast cancer.
Lancet
1998;351:1393–1396. Verdecchia P, Reboldi G, Schillaci G, et al. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension.
Circulation
1999;100:1802–1807. Also see: rbST Internal Review Team, Health Protection Branch.
rbST (Nutrilac) “Gaps Analysis” Report
. Ottawa: Health Canada, April 21, 1998.

12
. Cohen R.
Milk: The Deadly Poison
. Englewood Cliffs, NJ: Argus, 1998. Cohen R. Notmilk! Online:
www.hungerstrike.com
.

13
. Blaney DP, Miller JJ, Stillman RP.
Dairy: Background for 1995 Farm Legislation
(USDA Agricultural Economics Report No. 705), 1995. Schneider K. Grocers challenge use of new drug for milk output.
NYT
, February 4, 1994:A1,A14. Over 800 farmers report problems related to rBGH.
Nutrition Week
, June 2, 1995:6.

14
. Cohen B. Ben & Jerry’s Testifies Before FDA in Favor of BGH Labeling (press release). Waterbury, VT: Ben & Jerry’s, May 6, 1993.

15
. Kolata G. When the geneticists’ fingers get in the food.
NYT
, February 20, 1994:E13. Also see: DuPuis EM.
Nature’s Perfect Food
. New York University Press, 2002.

16
. OTA.
U.S. Dairy Industry at a Crossroad: Biotechnology and Policy
Choices
—
Special Report
(OTA-F-470), 1991. BGH moratorium.
Nutrition Week
, August 6, 1993:5.

17
. Schneider K. U.S. approves use of drug to raise milk production: gain for biotechnology.
NYT
, November 6, 1993:A1,A9. FDA. Animal drugs, feeds, and related products; sterile sometribove zinc suspension.
FR
58:59946–59947, November 12, 1993.

18
. Benson S, Arax M, Burstein R. A growing concern: as biotech crops come to market, neither scientists—who take industry money—nor federal regulators are adequately protecting consumers and farmers.
Mother Jones
, January/February 1997:36–43,66–71. Feder BJ. Monsanto has its wonder hormone: can it sell it?
NYT
, March 12, 1995:A8. Stauber JC, Rampton S.
Toxic Sludge Is Good for You: Lies, Damn Lies, and the Public Relations Industry
. Monroe, ME: Common Courage Press, 1995:55–59.

19
. Engelberg S. Democrats’ new overseer is everybody’s Mr. Inside.
NYT
, August 19, 1994:A1,A16.

20
. Coghlan A. Milk hormone data bottled up for years.
New Scientist
October 22, 1994:4. Millstone E, Brunner E, White I. Plagiarism or protecting public health?
Nature
1994;371:647–648.

21
. Wilson S. Fox in the cow barn.
Nation
, June 8, 1998:20. Montague P. How Monsanto “listens” to other opinions.
Ecologist
1998;28(5):299–300. Reporters win lawsuit to thwart Fox-TV cover-up.
BGH Bulletin
, undated, accessed December 15, 2001. Online:
www.foxbghsuit.com
.

22
. Schneider K. Lines drawn in a war over a milk hormone.
NYT
, March 9, 1994:A12.

23
. Weldon VV. Testimony to the Joint Meeting of the FDA Food and Veterinary Medicine Advisory Committee Meetings, Washington DC, May 6–7, 1993 (written statement distributed at the meeting). Dr. Weldon was then vice president for public policy, Monsanto.

24
. After committees meet, BGH decision left to FDA.
Nutrition Week
, May 14, 1993:2–3.

25
. FDA. Interim guidance on the voluntary labeling of milk and milk products from cows that have not been treated with recombinant bovine somatotropin.
FR
59:6279–6280, February 10, 1994.

26
. Schneider K. Maine and Vermont restrict dairies’ use of a growth hormone.
NYT
, April 15, 1994:A16.

27
. Kilman S. Dairy-food concerns launch products from cows not treated with hormone.
WSJ
, May 2, 1994:B7.

28
. Burros M. More milk, more confusion: what should the label say?
NYT
, May 18, 1994:C1,C4.

29
. King & Spalding. Mandatory labeling of milk and other foods derived from dairy cows supplemented with bovine somatotropin would be unlawful and unwise (memorandum). Washington, DC, April 28, 1993. A cover letter discloses the author as Mr. Richard A. Merrill, the former FDA counsel. These materials were included as part of the briefing materials for the FDA Food Advisory Committee hearings of May 6, 1993.

30
. Schneider K. Question is raised on hormone maker’s ties to F.D.A. aides.
NYT
, April 18, 1994:A9.

31
. GAO. Letter from Acting General Counsel Robert P. Murphy to the Honorables George E. Brown, Jr., David Obey, and Bernard Sanders (B257122), October 19, 1994. Quotations: 15,23.

32
. Sanders B. GAO uncovers appearances of impropriety in FDA’s approval of rBGH (press release). U.S. House of Representatives, October 30, 1994. The release included detailed summaries of the involvement of the three FDA employees.

33
. Bellow D. Vermont, the pure-food state.
Nation
, March 8, 1999:18–21. Brownlee S. Dollars for DNA: biotech seems near to living up to its hype.
US News & World Report
, May 25, 1998:48,50.

34
. Aldrich L, Blisard N. Consumer acceptance of biotechnology: lessons from the rbST experience.
Current Issues in Economics of Food Markets
(USDA Agriculture Information Bulletin No. 747-01), December 1998.

35
. Hoban TJ.
Consumer Awareness and Acceptance of Bovine Somatotropin (BST)
. Washington, DC: Grocery Manufacturers of America, 1994. Grobe D, Douthitt R, Zepeda L. A model of consumers’ risk perceptions toward recombinant bovine growth hormone (rBGH): the impact of risk characteristics.
Risk Analysis
1999;19:661–673.

36
. Gilbert S. Fears over milk, long dismissed, still simmer.
NYT
, January 19, 1999:F7.

37
. Kessler DA, Taylor MR, Maryanski JH, et al. The safety of foods developed by biotechnology.
Science
1992;256:1747–1749, 1832.

38
. FDA. Statement of policy: foods derived from new plant varieties: notice.
FR
57:22984–23005, May 29, 1992. Quotation: 22985.

39
. FDA. Premarket notice concerning bioengineered foods: proposed rule.
FR
66:4706–4738, January 18, 2001.

40
. Ingersoll B. New policy eases market path for bioengineered foods.
WSJ
, May 26, 1992: B1,B6.

41
. Kim J. Genetic agriculture gets go-ahead.
USA Today
, May 27, 1992:3B.

42
. Burros M. Documents show officials disagreed on altered food.
NYT
, December 1, 1999:A18. Druker SM.
Why Food and Drug Administration Policy on Genetically Engineered Food Violates Sound Science and U.S. Law
(presentation to FDA hearing, Washington, DC, November 30, 1999), at
www.biotech-info.net/druker.pdf
.

43
. Millstone E, Brunner E, Mayer S. Beyond “substantial equivalence.”
Nature
1999;401:525–526.

44
. Brozan N. Genetically engineered foods? Not in
their
kitchens!
NYT
, July 30, 1992:B6. Chefs urge boycotting new foods.
NYT
, June 3, 1992:C6.

45
. FDA.
Foods Derived from New Plant Varieties Derived through Recombinant DNA Technology: Final Consultations under FDA’s 1992 Policy
, July 2001, at
www.foodsafety.gov/~lrd/biocon.html
.

46
. Putnam JJ, Allshouse JE.
Food Consumption, Prices, and Expenditures, 1970–97
(Statistical Bulletin No. 965), USDA, 1999. Fisher LM. Developer of the new tomato expects a financial bonanza.
NYT
, May 19, 1994:B7. Hilts PJ. Genetically altered tomato moves toward U.S. approval.
NYT
, April 9, 1994:A7.

47
. Martineau B. Food fight.
The Sciences
2001;spring:24–29. Martineau B.
First Fruit: The Creation of the Flavr Savr Tomato and the Birth of Biotech Food
. New York: McGraw-Hill, 2001. Also see: Charles D.
Lords of the Harvest:
Biotech, Big Money, and the Future of Food
. Cambridge, MA: Perseus, 2001:126–148.

48
. Redenbaugh K, Hiatt W, Martineau B, et al.
Safety Assessment of Genetically Engineered Fruits and Vegetables: A Case Study of the Flavr Savr Tomato
. Boca Raton, FL: CRC Press, 1992. Stix G. A recombinant feast: new bioengineered crops move toward market.
Scientific American
1995;273:38–39.

49
. Seabrook J. Tremors in the hothouse.
New Yorker
, July 19, 1993:32–41. O’Neill M. Tomato review: no substitute for summer.
NYT
, May 19, 1994:B7.

50
. McMurray S. New Calgene tomato might have tasted just as good without genetic alteration.
WSJ
, January 12, 1993:B1. Fisher LM. Monsanto to acquire 49.9% of biotechnology company.
NYT
, June 29, 1995:D3.

51
. Safeway.
A Guide to Safeway Double Concentrated Tomato Puree Produced from Genetically Modified Tomatoes: Help and Advice
. Kent, UK: Safeway, [undated, c. 1998].

52
. Rogers D. Stores dodge GM food row.
Marketing
(London), June 18, 1998:14.

53
. Whitney CR. Europe loses its appetite for high-tech food.
NYT
, June 27, 1999:D3. Michael A. “GM-free” food labels are value-free.
Nature Biotechnology
1999;17:420.

54
. EPA. Proposed policy: plant-pesticides subject to the Federal Insecticide, Fungicide, and Rodenticide Act; and the Federal Food, Drug, and Cosmetic Act.
FR
59:60496—60518, November 23, 1994. EPA. Plant-pesticides subject to the Federal Insecticide, Fungicide, and Rodenticide Act: proposed rule.
FR
59:60519–60535, November 23, 1994.

55
. Rissler J, Mellon M.
The Ecological Risks of Engineered Crops
. Cambridge, MA: MIT Press, 1996. National Research Council.
Genetically Modified Pest-Protected Plants: Science and Regulation
. Washington, DC: National Academy Press, 2000.

56
. Miller H. A need to reinvent biotechnology regulation at the EPA.
Science
1994;266:1815–1818. Wadman M. GM advisory panel is slanted, say critics.
Nature
1999;399:7. Environmental Defense Fund (EDF). EDF Cautiously Praises EPA’s Proposed Genetic Engineering Rule (press release). New York, November 16, 1994. Plan to regulate gene-modified plants draws fire.
Illinois Agrinews
, August 1, 1997:A4.

57
. Hagmann M. EPA, critics soften stance on pesticidal plants.
Science
1999;284:249.

58
. EPA. Regulations under the Federal Insecticide, Fungicide, and Rodenticide Act for plant-incorporated protectants (formerly plant-pesticides): final rule.
FR
66:37771–37817, July 19, 2001. Quotation: 37781.

59
. EPA.
Biopesticides Registration Action Document:
Bacillus thuringiensis Plant-Incorporated Protectants, October 16, 2001, at
www.epa.gov/opp00001/biopesticides/pips/bt_brad.htm
.

60
. EPA. Pesticide labeling and other regulatory issues: final rule.
FR
66:64759–64768, December 14, 2001.

1
. Zepeda L. Don’t ask, don’t tell: U.S. policy on labeling of genetically engineered foods. In: Buttel FH, Goodman RM.
Of Frankenfoods and Golden Rice: Risks, Rewards, and Realities of Genetically Modified Foods
. Madison: Wisconsin Academy of Sciences, Arts and Letters, 2001:121–130.

2
. Poll Shows Broad but Limited Support for Labeling of Bioengineered Foods (press release). CSPI, May 16, 2001, at
www.cspinet.org/new/labeling_gefoods.html
.

3
. International Food Information Council. Most Americans can articulate expected benefits of biotechnology, November 2001, at
www.biotech-info.net/IFIC_research.html
.

4
. Fox JL. U.S. food labeling policy softens.
Nature Biotechnology
1999;17:847. Silva C, Leonard R. U.S. prepares to OK labels on GE foods.
Nutrition Week
, October 29, 1999:4–5.

5
.
Genetically Engineered Food Right to Know Act
. H.R. 3377, 106th Congress, 1st Session, November 16, 1999.

6
. Biotech foods bill would mandate labeling, impose civil penalties.
Food Regulation Weekly
, November 15, 1999:11–12.

7
. FDA. Biotechnology in the year 2000 and beyond; public meetings: notice.
FR
64:57470–57472, October 25, 1999.

8
. FDA.
Report on Consumer Focus Groups on Biotechnology
, February 2001, at
www.foodsafety.gov/~comm/biorpt.html
. The FDA conducted 12 focus groups from May 10 to 24, 2000.

9
. FDA. FDA to Strengthen Pre-market Review of Bioengineered Foods (press release). May 3, 2000. White House Briefing Room. Clinton Administration Agencies Announce Food and Agricultural Biotechnology Initiatives (press release). May 3, 2000.